The Use of Systemic Immune Moderators in Dermatology: An Update. 2000;18:1321. Br J Clin Pharmacol. Long-term risk of malignancy after treatment of inflammatory bowel disease with azathioprine. Weinstein, G., Lebwohl, M. Methotrexate in psoriasis: consensus conference. J Am Acad Dermatol. 2001;137:505506. 2003;149:138145. Pustular psoriasis is a rare form of psoriasis that et al, Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series. 2000;142:10571058. 1999;26:141149. 1997;137:587589. Weinstein, G., Lebwohl, M. Methotrexate in psoriasis: consensus conference. Advanced Search. Mark G. LebwohlxMark G. Treatment of patients with pustular psoriasis depends on the severity of presentation and patient’s underlying risk factors.
6 Lebwohl M., Advances in psoriasis therapy. Clin Exp Dermatol (2000) 25: pp 265-268. Br J Dermatol (2003) 149: pp 138-145. More recently, treatment with combinations of these agents, known as highly active antiretroviral therapy (HAART), has been used to suppress replication of HIV (Gulick et al. Production of AMEVIVE can be carried out as follows: CHO host cells are thawed, scaled up to a culture of 2000 L, maintained in culture for 6-7 days with pH control and nutrient feed (at 48 hrs. Taniguchi, M., European Patent Application 171,496; Neuberger et al. 149, Ferguson et al. 6162432, December 2000, Wallner et al. A Multicentre Study, British Journal of Dermatology, vol. British Journal of Dermatology, vol. 137, pp. 755-760, 1997. cited by other.
2000;2(6):481-5. A Multicentre Study, British Journal of Dermatology, vol. 149(7):2255-2261 (1992). 1 clinical trials of recombinant human TNF-a in patients with advanced cancer. EMBO J 2000: 19 (15): 41544163. Br J Dermatol 2003: 149 (5): 10461049. BC Decker Inc., Hamilton, Ontario, pp: 149-174. In: A Dermatotological View: From Physiology to Therapy, Maibach, H.I. (Ed.). Br. J. Dermatol., 128: 137-142. Taking the heartbreak out of psoriasis. Sci., 66: 587-589.